Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.[L6010,L52145]
Synonyms
Dextroamphetamine adipate
(αS)-α-methylbenzeneethanamine
Dexamfetaminum
(S)-amphetamine
(S)-1-phenyl-2-propylamine
(S)-(+)-β-phenylisopropylamine
(S)-α-methylbenzeneethanamine
Dextroamphetamine
d-amphetamine
(S)-1-phenyl-2-aminopropane
Dextroamphetamine sulfate
(+)-amphetamine
(+)-α-methylphenethylamine
(S)-(+)-amphetamine
Dexamfetamine
Dexamfetamina
Desamfetamina
(+)-(S)-amphetamine
Dexamphetamine
(+)-α-methylphenylethylamine
Dextroamphetamine saccharate
Dexanfetamina
Brand Names
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
Adderall XR
Dextroamphetamine Sulfate
Dexedrine
Procentra
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682